Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a novel medium throughput flow-cytometry based micro-neutralisation test for SARS-CoV-2 with applications in clinical vaccine trials and antibody screening.
O'Reilly S, Kenny G, Alrawahneh T, Francois N, Gu L, Angeliadis M, de Masson d'Autume V, Garcia Leon A, Feeney ER, Yousif O, Cotter A, de Barra E, Horgan M, Mallon PWG, Gautier V. O'Reilly S, et al. Among authors: feeney er. PLoS One. 2023 Nov 30;18(11):e0294262. doi: 10.1371/journal.pone.0294262. eCollection 2023. PLoS One. 2023. PMID: 38033116 Free PMC article.
Insulin resistance in treated HIV infection.
Feeney ER, Mallon PW. Feeney ER, et al. Best Pract Res Clin Endocrinol Metab. 2011 Jun;25(3):443-58. doi: 10.1016/j.beem.2010.11.002. Best Pract Res Clin Endocrinol Metab. 2011. PMID: 21663838 Review.
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial.
Feeney E, Wallace D, Cotter A, Tinago W, McCarthy C, Keane D, Hussain R, Alvarez Barco E, Doran P, Mallon P. Feeney E, et al. Trials. 2020 May 25;21(1):430. doi: 10.1186/s13063-020-04407-x. Trials. 2020. PMID: 32450915 Free PMC article. No abstract available.
Discharge-delaying factors for patients suitable for outpatient parenteral antimicrobial therapy (OPAT) in an Irish tertiary hospital during COVID-19.
Staunton S, Rajendran D, Maher P, McCann J, McNicholas S, Feeney E, O'Broin C, Savinelli S, Mallon P, Watson A, Waqas S. Staunton S, et al. JAC Antimicrob Resist. 2021 Oct 14;3(4):dlab163. doi: 10.1093/jacamr/dlab163. eCollection 2021 Dec. JAC Antimicrob Resist. 2021. PMID: 34661108 Free PMC article. No abstract available.
Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms.
Kenny G, McCann K, O'Brien C, Savinelli S, Tinago W, Yousif O, Lambert JS, O'Broin C, Feeney ER, De Barra E, Doran P, Mallon PWG; All-Ireland Infectious Diseases (AIID) Cohort Study Group. Kenny G, et al. Among authors: feeney er. Open Forum Infect Dis. 2022 Mar 7;9(4):ofac060. doi: 10.1093/ofid/ofac060. eCollection 2022 Apr. Open Forum Infect Dis. 2022. PMID: 35265728 Free PMC article.
56 results